Patents by Inventor Rolf Hellmann

Rolf Hellmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate
    Patent number: 11897847
    Abstract: The present invention relates to one crystalline form A of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate, a process for the production of this crystalline form, formulations for plant protection and herbicidal compositions comprising such form A.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: February 13, 2024
    Assignee: BASF SE
    Inventors: Martin Viertelhaus, Rolf Hellmann, Tobias Seiser, Cyrill Zagar, Gregory Armel, Ulrich Steinbrenner
  • Crystalline forms of ethyl 2-[[3-[[3- chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy] acetate
    Patent number: 11292784
    Abstract: The present invention relates to crystalline forms of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, herein after also referred to as “compound of formula (I)”. The invention also relates to a process for the production of these crystalline forms, formulations for plant protection and herbicidal compositions which contain one of these crystalline forms.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: April 5, 2022
    Assignee: BASF SE
    Inventors: Martin Viertelhaus, Rolf Hellmann, Dennis Koulelis, Tobias Seiser
  • CRYSTALLINE FORM OF ETHYL 2-[2-[2-CHLORO-4-FLUORO-5-[3-METHYL-2,6-DIOXO-4-(TRIFLUOROMETHYL)PYRIMIDIN-1-YL]PHENOXY]PHENOXY]ACETATE
    Publication number: 20210206729
    Abstract: The present invention relates to one crystalline form A of ethyl 2-[2-[2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]acetate, a process for the production of this crystalline form, formulations for plant protection and herbicidal compositions comprising such form A.
    Type: Application
    Filed: May 29, 2019
    Publication date: July 8, 2021
    Inventors: Martin Viertelhaus, Rolf Hellmann, Tobias Seiser, Cyrill Zagar, Gregory Armel, Ulrich Steinbrenner
  • CRYSTALLINE FORMS OF ETHYL 2-[[3-[[3- CHLORO-5-FLUORO-6-[3-METHYL-2,6-DIOXO- 4-(TRIFLUOROMETHYL)PYRIMIDIN-1-YL]-2- PYRIDYL]OXY]ACETATE
    Publication number: 20200354337
    Abstract: The present invention relates to crystalline forms of ethyl 2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy]-2-pyridyl]oxy]acetate, herein after also referred to as “compound of formula (I)”.
    Type: Application
    Filed: November 8, 2018
    Publication date: November 12, 2020
    Inventors: Martin Viertelhaus, Rolf Hellmann, Dennis Koulelis, Tobias Seiser
  • Multi-component crystals of vismodegib and selected co-crystal formers or solvents
    Patent number: 10105355
    Abstract: The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and solvents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: October 23, 2018
    Assignee: BASF SE
    Inventors: Martin Viertelhaus, Tiziana Chiodo, Beate Salvador, Marcus Vossen, Andreas Hafner, Tobias Hintermann, Walter Weishaar, Rolf Hellmann
  • MULTI-COMPONENT CRYSTALS OF VISMODEGIB AND SELECTED CO-CRYSTAL FORMERS OR SOLVENTS
    Publication number: 20170216266
    Abstract: The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and solvents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.
    Type: Application
    Filed: August 3, 2015
    Publication date: August 3, 2017
    Inventors: MARTIN VIERTELHAUS, Tiziana CHIODO, Beate SALVADOR, Marcus VOSSEN, Andreas HAFNER, Tobias HINTERMANN, Walter WEISHAAR, Rolf HELLMANN
  • Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
    Patent number: 9221789
    Abstract: Novel solid forms of imatinib mesilate comprising as active ingredient 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]-benzamide methanesulfonic acid salt and as co-crystal former benzoic acid, fumaric acid or succinic acid are described. The said multi-component crystalline forms possess improved physical and biological properties with respect to the crystalline forms of the active pharmaceutical ingredient previously known.
    Type: Grant
    Filed: June 18, 2013
    Date of Patent: December 29, 2015
    Assignee: BASF SE
    Inventors: Tiziana Chiodo, Rolf Hellmann, Marcus Vossen, Beate Salvador, Andreas Hafner, Tobias Hintermann
  • MULTICOMPONENT CRYSTALS COMPRISING IMATINIB MESILATE AND SELECTED CO-CRYSTAL FORMERS
    Publication number: 20150126520
    Abstract: Novel solid forms of imatinib mesilate comprising as active ingredient 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]-benzamide methanesulfonic acid salt and as co-crystal former benzoic acid, fumaric acid or succinic acid are described. The said multi-component crystalline forms possess improved physical and biological properties with respect to the crystalline forms of the active pharmaceutical ingredient previously known.
    Type: Application
    Filed: June 18, 2013
    Publication date: May 7, 2015
    Applicant: BASF SE
    Inventors: Tiziana Chiodo, Rolf Hellmann, Marcus Vossen, Beate Salvador, Andreas Hafner, Tobias Hintermann
  • Method for Testing Substances or Substance Mixtures and the Use Thereof
    Publication number: 20110160594
    Abstract: The present invention relates to a method for testing a substance or a substance mixture and the use thereof for identifying and/or characterizing the mode of action of the substance or the substance mixture or for determining the biochemical and/or metabolic state of an organism or group of organisms or part(s) thereof after exposure to the substance or the substance mixture.
    Type: Application
    Filed: September 4, 2009
    Publication date: June 30, 2011
    Applicant: BASF SE
    Inventors: Herbert Platsch, Helmut Schiffer, Rolf Hellmann, Stefan Emig, Wolfgang Grabarse, Harald Koehle, Klaus Grossmann, Juergen Langewald, Christine Boeddinghaus, John Dorsch